Optimal Therapeutic Sequencing in Relapsed/Refractory CLL: Incorporating Clinical and Real-World Data With Regional Guidance for Culturally-Sensitive and Individualized Care

Learn strategies for optimal therapeutic sequencing in relapsed/refractory CLL with downloadable slides, expert commentaries, and on-demand videos from live, expert-led webinars.

Share

Program Content

Activities

Treatment Sequencing in CLL
Optimal Therapeutic Sequencing in Relapsed/Refractory CLL: A Global Perspective
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: October 28, 2024

Expires: October 27, 2025

Previously Treated CLL
Optimal Therapeutic Sequencing in Relapsed/Refractory CLL: Key Information for Nurses, NPs, and PAs
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: November 05, 2024

Expires: November 04, 2025

Previously Treated CLL
Optimal Therapeutic Sequencing in Relapsed/Refractory CLL: Key Information for Pharmacists
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: November 11, 2024

Expires: November 10, 2025

Faculty

cover img faculity

Othman Al-Sawaf, MD

Hematologist & Medical Oncologist
Principal Investigator
University Hospital of Cologne
German CLL Study Group
Cologne, Germany

cover img faculity

Farrukh T. Awan, MD, MS, MBA

Associate Director, Section of Hematologic Malignancies/Transplantation and Cellular Therapy
Director of Lymphoid Malignancies Program
Harold C. Simmons Comprehensive Cancer Center
University of Texas Southwestern Medical Center
Dallas, Texas

cover img faculity

Karen M. Fancher, PharmD, BCOP

Associate Professor of Pharmacy Practice
Duquesne University School of Pharmacy
Clinical Pharmacy Specialist – Oncology
University of Pittsburgh Medical Center Passavant
Pittsburgh, Pennsylvania

cover img faculity

Nichole Fisher, RN, BSN

Clinical Research Supervisor
Willamette Valley Cancer Institute
Eugene, Oregon

cover img faculity

Amy Goodrich, RN, MSN, CRNP-AC

Nurse Practitioner
Johns Hopkins Kimmel Cancer Center
Baltimore, Maryland

cover img faculity

Josie Montegaard, MSN, AGPCNP-BC

Nurse Practitioner
Dana-Farber Cancer Institute
Boston, Massachusetts

cover img faculity

Anthony J. Perissinotti, PharmD, BCOP

Hematology Clinical Pharmacist Specialist
University of Michigan
Ann Arbor, Michigan

cover img faculity

Caitlin R. Rausch, PharmD, BCOP

Clinical Pharmacy Specialist, Leukemia
The University of Texas MD Anderson Cancer Center
Houston, Texas

cover img faculity

Alessandra Tedeschi, MD

Consultant in Hematology
Division of Hematology
Niguarda Hospital
Milano, Italy

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

Supported by an educational grant from Lilly.

Lilly